About NxStage
NxStage is a company based in Lawrence (United States) founded in 1998 was acquired by Fresenius Medical Care in August 2017. The company has 732 employees as of December 31, 2018. NxStage offers products and services including VersiHD System, VersiHD with GuideMe Software, and System One Portable Hemodialysis Machine. NxStage operates in a competitive market with competitors including Outset Medical, Fresenius, Hemotune, Diality and Chongqing Shanwaishan Blood Purification Technology, among others.
- Headquarter Lawrence, United States
- Employees 732 as on 31 Dec, 2018
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fresenius Medical Care
-
Annual Revenue
$393.94 M (USD)8as on Dec 31, 2017
-
Net Profit
-$13.99 M (USD)-193as on Dec 31, 2017
-
EBITDA
-$13.85 M (USD)-223as on Dec 31, 2017
-
Latest Funding Round
Not available
- Investors
-
Employee Count
732
as on Dec 31, 2018
-
Acquired by
Fresenius Medical Care
(Aug 07, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NxStage
NxStage offers a comprehensive portfolio of products and services, including VersiHD System, VersiHD with GuideMe Software, and System One Portable Hemodialysis Machine.
Portable device for home hemodialysis treatments.
Assists in managing home hemodialysis sessions.
Enables flexible dialysis at home or while traveling.
People of NxStage
Unlock access to complete
Unlock access to complete
Software Development Team
101 people
Leadership Team
54 people
Finance and Accounting
29 people
Senior Team
24 people
Operations Team
19 people
Data Analysis and Operations Team
11 people
Member Team
10 people
Product Management Team
6 people
Unlock access to complete
Funding Insights of NxStage
Detailed funding history for NxStage
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in NxStage
NxStage has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fresenius Medical Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and services for chronic kidney failure patients are developed.
|
Locked | Locked | Locked |
Investor details for NxStage
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NxStage
Investment portfolio details for NxStage
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NxStage
Detailed financials for NxStage
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nxstage Comparisons
Peer comparison for NxStage
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NxStage
NxStage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Outset Medical, Fresenius, Hemotune, Diality and Chongqing Shanwaishan Blood Purification Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hemodialysis machines with touchscreen displays are provided for medical use.
|
|
| Locked | Locked | Locked |
System-critical products and services for healthcare therapies are provided.
|
|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Developer of portable hemodialysis device
|
|
| Locked | Locked | Locked |
Blood purification equipment for kidney failure patients is provided.
|
Detailed competitors of NxStage
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nxstage
Complete news archive for NxStage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NxStage
NxStage was founded in 1998.
NxStage is headquartered in Lawrence, United States. It is registered at Lawrence, Kansas, United States.
As of Dec 31, 2018, the latest employee count at NxStage is 732.
Annual revenue of NxStage is $393.94M as on Dec 31, 2017.
NxStage develops, manufactures and markets products for the treatment of end-stage renal disease, kidney failure, and fluid overload. The fladship product, System One has both home and critical care applications. The product went public in 2005. The company acquired Medisystems in 2007.
NxStage's top competitors include Outset Medical, Fresenius and Diality.
NxStage offers VersiHD System, VersiHD with GuideMe Software, and System One Portable Hemodialysis Machine.
NxStage has 1 investor. Key investors include Fresenius Medical Care.